Global map > Innovations > North America and Caribbean > United States > Brea > Beckman Coulter
Beckman Coulter icon
Beckman Coulter announced the availability of SARS-CoV-2 IgG II Assay, a semi-quantitative COVID-19 serology tool which helps clinicians can establish a baseline to evaluate an individual’s immune status based on the numerical value and assess relative changes in an individual’s response to the SARS-CoV-2 virus over time.
Rankings by SemRush
National Ranking
in United States
Regional Ranking
in North America and Caribbean
Global Ranking
Loading startups...